Clinicopathological Criteria Defining Mucinous Appendiceal Tumors from 2476 Appendectomies: a Single-Center Retrospective Study.
Acute appendicitis
Histopathological classification
LMANs
MACAs
Mucinous appendiceal tumors
Pseudomyxoma peritonei
Journal
Journal of gastrointestinal cancer
ISSN: 1941-6636
Titre abrégé: J Gastrointest Cancer
Pays: United States
ID NLM: 101479627
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
pubmed:
30
11
2018
medline:
4
11
2020
entrez:
29
11
2018
Statut:
ppublish
Résumé
Mucinous appendiceal tumors (MATs) constitute 0.2-0.3% of appendectomies. This retrospective chart review study determines the incidence of MATs among appendectomies at King Abdul-Aziz Specialist Hospital, Taif City, Saudi Arabia, from January 2009 to December 2014. The clinicopathological features, histopathological criteria, management, outcomes of patients, and the impact of histopathological classification on the follow-up period and recurrence are evaluated. Demographic and clinicopathological data were collected from medical records. Microscopic slides from 2476 appendectomies were re-examined to diagnose and classify MATs into low-grade mucinous neoplasms (LAMNs) and mucinous adenocarcinomas (MACAs). CK20, CK7, and cdx2 immunohistochemistry was applied for evaluating pseudomyxoma peritonei. Data were expressed as numbers, percentages, and mean ± standard deviation. Nine MATs were diagnosed with an incidence of 0.36% of appendectomies, a male:female ratio of 1.25:1 and a mean age of 57.2 years. Acute appendicitis was the commonest clinical presentation. About 66.7% were LAMNs and 33.3% MACAs. Beside appendectomy, MACAs were managed with right hemicolectomy and chemotherapy. The median follow-up was 34 months with recurrence and liver metastases in two MACAs. No recurrences for LAMNs. MATs constitute 0.36% of all appendectomies. Classifying MATs into LAMNs and MACAs is more applicable for both clinical and pathology practices as compared to the three- or four-tiered classification schemes.
Identifiants
pubmed: 30484138
doi: 10.1007/s12029-018-0182-4
pii: 10.1007/s12029-018-0182-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
10-16Références
World J Gastroenterol. 2009 Mar 28;15(12):1472-4
pubmed: 19322920
Eur J Surg Oncol. 2010 Aug;36(8):763-71
pubmed: 20561765
Ann Surg. 1994 Jan;219(1):51-7
pubmed: 8297177
Trop Gastroenterol. 2004 Jan-Mar;25(1):36-9
pubmed: 15303471
Medicine (Baltimore). 2017 Feb;96(5):e6016
pubmed: 28151903
Am J Surg Pathol. 2009 Oct;33(10):1425-39
pubmed: 19641451
Am J Surg Pathol. 2003 Aug;27(8):1089-103
pubmed: 12883241
Sci Rep. 2016 Dec 16;6:39027
pubmed: 27982068
World J Gastroenterol. 2011 Aug 14;17(30):3531-7
pubmed: 21941421
Cancer. 2016 Jan 15;122(2):213-21
pubmed: 26506400
World J Gastroenterol. 2013 Jul 7;19(25):4015-22
pubmed: 23840147
Radiographics. 2003 May-Jun;23(3):645-62
pubmed: 12740466
Neuroendocrinology. 2008;87(1):20-30
pubmed: 17934252
Gastroenterology Res. 2009 Aug;2(4):238-241
pubmed: 27942282
Hum Pathol. 2017 Nov;69:81-89
pubmed: 28970138
J Gastroenterol. 2006 Aug;41(8):745-9
pubmed: 16988762
World J Gastroenterol. 2011 Apr 21;17(15):1961-70
pubmed: 21528073
Clin Colon Rectal Surg. 2015 Dec;28(4):247-55
pubmed: 26648795
Turk J Surg. 2017 Dec 01;33(4):274-278
pubmed: 29260132
Case Rep Oncol Med. 2016;2016:2161952
pubmed: 27066284
Mod Pathol. 2015 Jan;28 Suppl 1:S67-79
pubmed: 25560600
Indian J Surg Oncol. 2016 Jun;7(2):258-67
pubmed: 27065718
Arch Pathol Lab Med. 2010 Nov;134(11):1612-20
pubmed: 21043814
Ann Surg. 2013 Jun;257(6):1072-8
pubmed: 23001080
Hong Kong Med J. 2010 Feb;16(1):12-7
pubmed: 20124568
World J Surg Oncol. 2016 Nov 11;14(1):283
pubmed: 27835997
Ulus Travma Acil Cerrahi Derg. 2017 May;23(3):230-234
pubmed: 28530777
Int J Surg. 2015 Jun;18:132-5
pubmed: 25917270